Change to Business Description and Revenue Disclosure by Product Category
First written in FY2025-H1. 3 of 6 entries say "Restated". Latest entry: 2026-08-07.
2 other companies' latest entry also says "Reframed".
- FY2026RestatedAnnual report
「Net sales broken down by product category are as follows. Gelatin 27,410 Collagen peptides 7,265 Food materials 3,002 Biomedical 369 Total 38,048」
The Company has continued its revenue disclosure changed from sales categories to product categories, disclosing net sales for the 4 product categories. - FY2026-H1RestatedAnnual report
「Net sales broken down by product category are as follows. Gelatin 13,480 Collagen peptides 3,309 Food materials 1,525 Biomedical 183 Total 18,499」
The Company has continued its revenue disclosure changed from sales categories to product categories, disclosing net sales for gelatin, collagen peptides, food materials and biomedical. - FY2025RestatedAnnual report
「From the current consolidated fiscal year, the Company has changed the description of its business from the previous sales categories (Food Solutions, Health Support and Specialties) to product categories (gelatin, collagen peptides, food materials and biomedical).」
The Company has continued to provide business descriptions and revenue disclosure by product category in its annual report. Net sales were ¥28,821 million for gelatin, ¥6,489 million for collagen peptides, ¥3,085 million for food materials and ¥349 million for biomedical. - FY2025-H1First statedAnnual report
「The Group applies a single segment, the collagen business. From the current interim consolidated accounting period, however, it has changed the description of its business from the previous sales categories (Food Solutions, Health Support and Specialties) to product categories (gelatin, collagen peptides, food materials and biomedical).」
Changed from descriptions by the previous sales categories to descriptions and revenue disclosure by product category: gelatin, collagen peptides, food materials and biomedical.